The Global Bone Marrow Transplantation Market Size valued for USD 11.1 Billion in 2021 and is anticipated to reach USD 18.1 Billion by 2030 with a CAGR of 5.7% from 2022 to 2030.

A bone marrow transplant is a procedure that replaces bone marrow that isn't producing enough healthy blood cells with healthy blood-forming stem cells. A stem cell transplant is another name for a bone marrow transplant.

A hematopoietic stem cell transplant, or simply a stem cell transplant, is another name for a bone marrow transplant. Leukemia, myeloma, lymphoma, and other blood and immune system disorders that affect the bone marrow can all be treated with transplantation.

Surgery is not BMT. Through an intravenous (IV) catheter or tube, the new cells are introduced into the bloodstream. It is comparable to receiving blood or medication through an IV. The cells then enter the marrow from there.

Market Dynamics

A bone marrow transplant is intended to treat a variety of illnesses, including cancer. A bone marrow transplant may be required when the chemotherapy or radiation doses required to treat a cancer are so high that the patient's bone marrow stem cells will be irreparably harmed or destroyed by the treatment. If a disease has destroyed the bone marrow, bone marrow transplants may also be required.

The rise in the prevalence of blood cancer and other blood-related diseases is the main factor affecting the bone marrow transplant industry. It is anticipated that the forum will advance during the forecast period thanks to the statistics predicted by the FMI experts.

Long-term market growth is likely to be fueled by the increasing prevalence of diseases like non-Hodgkin and Hodgkin lymphoma, thalassemia, and leukaemia as well as common bone marrow diseases worldwide, technological advancements, and improvements to the healthcare system.

In the upcoming years, it is anticipated that an increase in mergers and acquisitions will help the industry grow. For instance, in September 2017, the U.S.-based gene therapy company Rocket Pharmaceuticals and Inotek Pharmaceuticals signed a binding merger agreement. The combined business will continue to be known as Rocket Pharmaceuticals and have its headquarters in New York City, subject to shareholder approval.

Market Insights

The global bone marrow transplantation market is split on the type, indications, end-user, and geography.

The type segment is further split into allogeneic bone marrow transplant and autologous bone marrow transplant. Among them, autologous bone marrow transplant sub-segment accounted for majority of the share. However, the allogeneic bone marrow transplant sub-segment is anticipated to attain the quickest CAGR during the forecast period from 2022 to 2030.

Acute leukaemia, solid tumours, multiple myelomas, hodgkin lymphoma, non-hodgkin lymphoma, and other conditions are included in the indications segmentation. According to the forecast for the market for bone marrow transplantation, acute leukaemia is anticipated to experience rapid market growth over the following few years. Furthermore, during the anticipated period from 2022 to 2030, solid tumours are likely to experience a significant growth rate. End-user segment is sub-segment into hospitals, multispecialty clinics, and ambulatory surgical centre.

Global Bone Marrow Transplantation Market Geographical Competition

The North America, Europe, Latin America, Asia-Pacific, and the Middle East & Africa regions make up the five geographical segments of the global Bone Marrow Transplantation market. With 60% of the global market share, Europe is anticipated to maintain its top position in comparison to other regions. Europe is the largest region, with North America coming in second. As the population ages and chronic diseases like blood cancer become more prevalent, the bone marrow industry will help the region prosper. The demand for effective bone marrow transplantation may not be as great in the Asia-Pacific region as it is in the European and North American markets, which will also grow to be significant medical tourism markets.

Global Bone Marrow Transplantation Industry Segment Analysis

Bone Marrow Transplantation Market By Type

·         Allogeneic Bone Marrow Transplant

·         Autologous Bone Marrow Transplant

Bone Marrow Transplantation Market By Indications

·         Hodgkin Lymphoma

·         Acute Leukaemia

·         Multiple Myelomas

·         Solid Tumours

·         Non-Hodgkin Lymphoma

·         Others

Bone Marrow Transplantation Market By End-User

·         Hospitals

·         Multispecialty Clinics

·         Ambulatory Surgical Centre

·         Others

Bone Marrow Transplantation Market Leading Companies

This section of the study honors the market's top vendors Abbott, Agendia, AllCells LLC, Conversant Bio, Diadexus Inc., Lonza Group Ltd., Merck Millipore Corporation, Sanofi, STEMCELL Technologies, and Qiagen N.V.

Bone Marrow Transplantation Market Regions